Innate Pharma S.A. (EPA:IPH)
2.200
+0.100 (4.76%)
Feb 21, 2025, 5:37 PM CET
Innate Pharma Employees
Innate Pharma had 179 employees as of December 31, 2023. The number of employees decreased by 32 or -15.17% compared to the previous year.
Employees
179
Change (1Y)
-32
Growth (1Y)
-15.17%
Revenue / Employee
€201,119
Profits / Employee
€202,690
Market Cap
184.39M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 200,000 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 10,662 |
bioMérieux | 13,982 |
Eurofins Scientific SE | 63,000 |
Ipsen | 5,325 |
Virbac | 5,459 |
emeis Société anonyme | 77,954 |
Innate Pharma News
- 3 days ago - Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments - Seeking Alpha
- 5 days ago - Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome - Business Wire
- 26 days ago - Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
- 26 days ago - Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors - Business Wire
- 4 weeks ago - Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York - Business Wire
- 6 weeks ago - Innate Pharma Announces Transformative Strategy to Accelerate Growth - Business Wire
- 2 months ago - Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Innate Pharma presents lacutamab improved health-related quality of life data at ASH 2024 - Seeking Alpha